80 related articles for article (PubMed ID: 7521423)
1. [Study for relapse cases of chronic hepatitis C treated with interferon (IFN) and approach to more successful re-treatment of IFN].
Iwabuchi S; Yoshida H; Fukui S
Nihon Rinsho; 1994 Jul; 52(7):1810-6. PubMed ID: 7521423
[TBL] [Abstract][Full Text] [Related]
2. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of retreatment of chronic hepatitis C with interferon (IFN) for non-complete responders on initial treatment].
Toyoda H; Nakano S; Kumada T
Nihon Rinsho; 1994 Jul; 52(7):1798-803. PubMed ID: 7521421
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
5. Retreatment of chronic hepatitis C with interferon.
Toyoda H; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Suga T; Ohki H; Ito O
Am J Gastroenterol; 1994 Sep; 89(9):1453-7. PubMed ID: 7521572
[TBL] [Abstract][Full Text] [Related]
6. [Significance of total dose of IFN in the treatment of chronic hepatitis C].
Imazeki F; Yokosuka O
Nihon Rinsho; 1994 Jul; 52(7):1794-7. PubMed ID: 7521420
[TBL] [Abstract][Full Text] [Related]
7. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
[TBL] [Abstract][Full Text] [Related]
8. [Examination in clinical course of HCV in interferon treatment].
Kumada H
Nihon Rinsho; 1994 Jul; 52(7):1832-5. PubMed ID: 7521426
[TBL] [Abstract][Full Text] [Related]
9. [The indication and the evaluation of IFN treatment of chronic hepatitis C].
Yano M
Nihon Rinsho; 1994 Jul; 52(7):1778-83. PubMed ID: 7521417
[TBL] [Abstract][Full Text] [Related]
10. [Serum HCV-RNA for evaluation of interferon-readministration to the former non responders in chronic hepatitis C].
Sata M; Tanikawa K
Nihon Rinsho; 1994 Jul; 52(7):1804-9. PubMed ID: 7521422
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
Martinot-Peignoux M; Marcellin P; Pouteau M; Castelnau C; Boyer N; Poliquin M; Degott C; Descombes I; Le Breton V; Milotova V
Hepatology; 1995 Oct; 22(4 Pt 1):1050-6. PubMed ID: 7557850
[TBL] [Abstract][Full Text] [Related]
12. Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection.
Davis GL; Lau JY
J Hepatol; 1995; 22(1 Suppl):110-4. PubMed ID: 7602061
[TBL] [Abstract][Full Text] [Related]
13. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial.
Kasahara A; Hayashi N; Hiramatsu N; Oshita M; Hagiwara H; Katayama K; Kato M; Masuzawa M; Yoshihara H; Kishida Y
Hepatology; 1995 Feb; 21(2):291-7. PubMed ID: 7843696
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
Hopf U; Berg T; König V; Küther S; Heuft HG; Lobeck H
J Hepatol; 1996; 24(2 Suppl):67-73. PubMed ID: 8836892
[TBL] [Abstract][Full Text] [Related]
15. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
[TBL] [Abstract][Full Text] [Related]
16. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta.
Kobayashi Y; Watanabe S; Konishi M; Yokoi M; Kakehashi R; Kaito M; Kondo M; Hayashi Y; Jomori T; Suzuki S
Hepatology; 1993 Dec; 18(6):1319-25. PubMed ID: 8244255
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
18. [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C: method and clinical significance on interferon (IFN) therapy].
Osada T; Iwabuchi S; Takatori M; Murayama M; Iino S
Nihon Rinsho; 1994 Jul; 52(7):1747-53. PubMed ID: 7521414
[TBL] [Abstract][Full Text] [Related]
19. [A trial of new interferon therapy for the patients with chronic hepatitis C resistant to interferon therapy].
Arase Y; Kumada H
Nihon Rinsho; 2001 Jul; 59(7):1309-14. PubMed ID: 11494543
[TBL] [Abstract][Full Text] [Related]
20. [Prediction of the outcome of IFN therapy in type C chronic hepatitis from serological grouping of hepatitis C virus].
Sakai A; Yanagi M; Unoura M; Kobayashi K
Nihon Rinsho; 1994 Jul; 52(7):1759-62. PubMed ID: 7521415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
